Summary

The global market for Medical Nutrition was estimated to be worth US$ 62620 million in 2024 and is forecast to a readjusted size of US$ 81340 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Medical nutrition refers to a group of medical food products used under the supervision of health practitioners for the nutritional management of a condition or disease. Medical nutrition products address a distinct nutritional requirement and provide adequate amounts of nutrients to the specific patient group.
Market Driver:
The growing prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders is a major driver for the medical nutrition products market. With an aging global population and increasing awareness of disease-related malnutrition, the demand for specialized nutritional solutions is rising. Additionally, advancements in medical nutrition formulations, such as plant-based, protein-rich, and immune-boosting supplements, are enhancing their effectiveness and expanding their adoption in clinical and home care settings. Government initiatives and healthcare policies promoting nutritional interventions further contribute to market growth, ensuring better patient outcomes and reducing healthcare costs.
Market Challenge:
Despite its growth potential, the medical nutrition products market faces challenges related to high costs and regulatory hurdles. The development and approval of medical nutrition products require extensive clinical research and compliance with stringent regulations, leading to high production costs and limiting affordability for some patients. Moreover, limited awareness and access to these products, particularly in developing regions, hinder market expansion. Reimbursement issues in several countries also pose a barrier, as many insurance providers do not fully cover medical nutrition therapies, restricting their widespread adoption in healthcare settings.
This report aims to provide a comprehensive presentation of the global market for Medical Nutrition, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Nutrition by region & country, by Type, and by Application.
The Medical Nutrition market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Nutrition.
Market Segmentation
By Company
Abbott Nutrition
Nestlé
Mead Johnson
Fresenius Kabi
Groupe Danone
Glanbia Performance Nutrition
Baxter
B. Braun
Grifols
Ajinomoto
Infaprim
Otsuka Pharmaceutical
Kelun Medical
JW Pharma
Hiseco Pharmaceutical Group
Tianjin Pharmaceutical (Jinyao Pharmaceutical)
Chenxin Pharmaceutical
Anhui Fengyuan Pharmaceutical
Segment by Type
Parenteral
Oral
Enteral
Segment by Application
Hospitals
Retail Pharmacy
E-Commerce
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Nutrition company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Nutrition in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Nutrition in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Medical Nutrition Product Introduction
1.2 Global Medical Nutrition Market Size Forecast (2020-2031)
1.3 Medical Nutrition Market Trends & Drivers
1.3.1 Medical Nutrition Industry Trends
1.3.2 Medical Nutrition Market Drivers & Opportunity
1.3.3 Medical Nutrition Market Challenges
1.3.4 Medical Nutrition Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Nutrition Players Revenue Ranking (2024)
2.2 Global Medical Nutrition Revenue by Company (2020-2025)
2.3 Key Companies Medical Nutrition Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Nutrition Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Nutrition
2.6 Medical Nutrition Market Competitive Analysis
2.6.1 Medical Nutrition Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Medical Nutrition Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Nutrition as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Parenteral
3.1.2 Oral
3.1.3 Enteral
3.2 Global Medical Nutrition Sales Value by Type
3.2.1 Global Medical Nutrition Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Medical Nutrition Sales Value, by Type (2020-2031)
3.2.3 Global Medical Nutrition Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Retail Pharmacy
4.1.3 E-Commerce
4.1.4 Other
4.2 Global Medical Nutrition Sales Value by Application
4.2.1 Global Medical Nutrition Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Medical Nutrition Sales Value, by Application (2020-2031)
4.2.3 Global Medical Nutrition Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Medical Nutrition Sales Value by Region
5.1.1 Global Medical Nutrition Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Medical Nutrition Sales Value by Region (2020-2025)
5.1.3 Global Medical Nutrition Sales Value by Region (2026-2031)
5.1.4 Global Medical Nutrition Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Medical Nutrition Sales Value, 2020-2031
5.2.2 North America Medical Nutrition Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Medical Nutrition Sales Value, 2020-2031
5.3.2 Europe Medical Nutrition Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Nutrition Sales Value, 2020-2031
5.4.2 Asia Pacific Medical Nutrition Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Medical Nutrition Sales Value, 2020-2031
5.5.2 South America Medical Nutrition Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Nutrition Sales Value, 2020-2031
5.6.2 Middle East & Africa Medical Nutrition Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Nutrition Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Medical Nutrition Sales Value, 2020-2031
6.3 United States
6.3.1 United States Medical Nutrition Sales Value, 2020-2031
6.3.2 United States Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Medical Nutrition Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Medical Nutrition Sales Value, 2020-2031
6.4.2 Europe Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Medical Nutrition Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Medical Nutrition Sales Value, 2020-2031
6.5.2 China Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.5.3 China Medical Nutrition Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Medical Nutrition Sales Value, 2020-2031
6.6.2 Japan Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Medical Nutrition Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Medical Nutrition Sales Value, 2020-2031
6.7.2 South Korea Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Medical Nutrition Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Nutrition Sales Value, 2020-2031
6.8.2 Southeast Asia Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Medical Nutrition Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Medical Nutrition Sales Value, 2020-2031
6.9.2 India Medical Nutrition Sales Value by Type (%), 2024 VS 2031
6.9.3 India Medical Nutrition Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott Nutrition
7.1.1 Abbott Nutrition Profile
7.1.2 Abbott Nutrition Main Business
7.1.3 Abbott Nutrition Medical Nutrition Products, Services and Solutions
7.1.4 Abbott Nutrition Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.1.5 Abbott Nutrition Recent Developments
7.2 Nestlé
7.2.1 Nestlé Profile
7.2.2 Nestlé Main Business
7.2.3 Nestlé Medical Nutrition Products, Services and Solutions
7.2.4 Nestlé Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.2.5 Nestlé Recent Developments
7.3 Mead Johnson
7.3.1 Mead Johnson Profile
7.3.2 Mead Johnson Main Business
7.3.3 Mead Johnson Medical Nutrition Products, Services and Solutions
7.3.4 Mead Johnson Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.3.5 Mead Johnson Recent Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Profile
7.4.2 Fresenius Kabi Main Business
7.4.3 Fresenius Kabi Medical Nutrition Products, Services and Solutions
7.4.4 Fresenius Kabi Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.4.5 Fresenius Kabi Recent Developments
7.5 Groupe Danone
7.5.1 Groupe Danone Profile
7.5.2 Groupe Danone Main Business
7.5.3 Groupe Danone Medical Nutrition Products, Services and Solutions
7.5.4 Groupe Danone Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.5.5 Groupe Danone Recent Developments
7.6 Glanbia Performance Nutrition
7.6.1 Glanbia Performance Nutrition Profile
7.6.2 Glanbia Performance Nutrition Main Business
7.6.3 Glanbia Performance Nutrition Medical Nutrition Products, Services and Solutions
7.6.4 Glanbia Performance Nutrition Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.6.5 Glanbia Performance Nutrition Recent Developments
7.7 Baxter
7.7.1 Baxter Profile
7.7.2 Baxter Main Business
7.7.3 Baxter Medical Nutrition Products, Services and Solutions
7.7.4 Baxter Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.7.5 Baxter Recent Developments
7.8 B. Braun
7.8.1 B. Braun Profile
7.8.2 B. Braun Main Business
7.8.3 B. Braun Medical Nutrition Products, Services and Solutions
7.8.4 B. Braun Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.8.5 B. Braun Recent Developments
7.9 Grifols
7.9.1 Grifols Profile
7.9.2 Grifols Main Business
7.9.3 Grifols Medical Nutrition Products, Services and Solutions
7.9.4 Grifols Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.9.5 Grifols Recent Developments
7.10 Ajinomoto
7.10.1 Ajinomoto Profile
7.10.2 Ajinomoto Main Business
7.10.3 Ajinomoto Medical Nutrition Products, Services and Solutions
7.10.4 Ajinomoto Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.10.5 Ajinomoto Recent Developments
7.11 Infaprim
7.11.1 Infaprim Profile
7.11.2 Infaprim Main Business
7.11.3 Infaprim Medical Nutrition Products, Services and Solutions
7.11.4 Infaprim Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.11.5 Infaprim Recent Developments
7.12 Otsuka Pharmaceutical
7.12.1 Otsuka Pharmaceutical Profile
7.12.2 Otsuka Pharmaceutical Main Business
7.12.3 Otsuka Pharmaceutical Medical Nutrition Products, Services and Solutions
7.12.4 Otsuka Pharmaceutical Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.12.5 Otsuka Pharmaceutical Recent Developments
7.13 Kelun Medical
7.13.1 Kelun Medical Profile
7.13.2 Kelun Medical Main Business
7.13.3 Kelun Medical Medical Nutrition Products, Services and Solutions
7.13.4 Kelun Medical Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.13.5 Kelun Medical Recent Developments
7.14 JW Pharma
7.14.1 JW Pharma Profile
7.14.2 JW Pharma Main Business
7.14.3 JW Pharma Medical Nutrition Products, Services and Solutions
7.14.4 JW Pharma Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.14.5 JW Pharma Recent Developments
7.15 Hiseco Pharmaceutical Group
7.15.1 Hiseco Pharmaceutical Group Profile
7.15.2 Hiseco Pharmaceutical Group Main Business
7.15.3 Hiseco Pharmaceutical Group Medical Nutrition Products, Services and Solutions
7.15.4 Hiseco Pharmaceutical Group Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.15.5 Hiseco Pharmaceutical Group Recent Developments
7.16 Tianjin Pharmaceutical (Jinyao Pharmaceutical)
7.16.1 Tianjin Pharmaceutical (Jinyao Pharmaceutical) Profile
7.16.2 Tianjin Pharmaceutical (Jinyao Pharmaceutical) Main Business
7.16.3 Tianjin Pharmaceutical (Jinyao Pharmaceutical) Medical Nutrition Products, Services and Solutions
7.16.4 Tianjin Pharmaceutical (Jinyao Pharmaceutical) Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.16.5 Tianjin Pharmaceutical (Jinyao Pharmaceutical) Recent Developments
7.17 Chenxin Pharmaceutical
7.17.1 Chenxin Pharmaceutical Profile
7.17.2 Chenxin Pharmaceutical Main Business
7.17.3 Chenxin Pharmaceutical Medical Nutrition Products, Services and Solutions
7.17.4 Chenxin Pharmaceutical Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.17.5 Chenxin Pharmaceutical Recent Developments
7.18 Anhui Fengyuan Pharmaceutical
7.18.1 Anhui Fengyuan Pharmaceutical Profile
7.18.2 Anhui Fengyuan Pharmaceutical Main Business
7.18.3 Anhui Fengyuan Pharmaceutical Medical Nutrition Products, Services and Solutions
7.18.4 Anhui Fengyuan Pharmaceutical Medical Nutrition Revenue (US$ Million) & (2020-2025)
7.18.5 Anhui Fengyuan Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Medical Nutrition Industrial Chain
8.2 Medical Nutrition Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Nutrition Sales Model
8.5.2 Sales Channel
8.5.3 Medical Nutrition Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer